Consistent with these findings, we found downregulation of integrins β1 and β3 in LGG and to a lesser extent in GBM with IDH1 mutation and upregulation of integrins β1 and β3 in EGFR-mutated LGG (Supplementary Fig. S8). This evidence concerns the gene IDH1 and glioblastoma.